Explore turnkey bio-compatible skin formulas engineered for sensitive skin recovery, post-procedure rehabilitation, and structural moisture barrier reinforcement.
A macroeconomic and biochemical assessment of barrier therapeutics, driven by environmental disruption, clinical dermatology routines, and shifting consumer expectations.
Modern lifestyle shifts, excessive mechanical peeling, and exposure to airborne particulate matter (PM2.5) have catalyzed a global epidemic of impaired stratum corneum function. Consumers are moving away from harsh acid exfoliation toward lipid-replenishing, restorative formulations that normalize Transepidermal Water Loss (TEWL).
Global beauty markets are transitioning from traditional decorative cosmetics to "corneotherapy-inspired" medical aesthetics. Brand owners require OEM/ODM suppliers to provide verified clinical efficacy, including hypoallergenic validation, non-comedogenic trials, and sterile packaging compatibility.
Brand scaling demands robust production capabilities backed by stringent global regulatory alignment. Operating two self-owned plants (Guangzhou Aoyan & Guangzhou Xinzimei Cosmetics), Beaza ensures uninterrupted supply chains, rigorous quality checks, and rapid documentation turnaround.
Deploying specialized repairing profiles tuned to climate stress vectors, regional compliance protocols, and specific skin phototypes.
Formulations destined for ultra-arid, high-UV markets prioritize heat-stable barrier recovery matrices. Emulsions utilize lightweight biomimetic squalane, ecotin shields, and thermal mineral hydrolysates designed to avoid heavy grease films under 45°C ambient temperatures.
Turnkey solutions complying precisely with EU Cosmetics Regulation (EC) No 1223/2009 and MoCRA guidelines. Formulations exclude controversial preservation agents, microplastics, and restricted silicones while maximizing eco-certified functional lipids.
High humidity combined with intense sun exposure causes sensitized, acne-prone barrier impairment. Repair systems utilize micro-emulsified watery serums, centella asiatica bio-ferments, and low-viscosity non-comedogenic gel-creams with anti-microbial support.
Architecting repair products using our "1+2+2+N+N" innovation matrix—coupling raw material genomics with scalable continuous manufacturing.
Selection of bioactive carriers, lipid-replenishment systems, and functional stabilizers tailored to targeted clinical claims.
Utilizing micro-fluidization to reduce particle diameters under 200nm, ensuring enhanced cellular absorption without pore-clogging.
GMPC-compliant sterile filling lines equipped with laminar HEPA air cascades to prevent bio-contamination of delicate repair formulas.
Every private label iteration undergoes strict analytical verification across its development lifecycle:
Eliminate time-to-market bottlenecks with complete document readiness handled directly by our regulatory affairs wing:
High-performance private label cleansers, treatments, and daily defense formulas built to preserve physiological barrier integrity.
In-depth responses covering OEM vs ODM specifications, clinical trials, regulatory compliance, and production minimums.